We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.9%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$312M
AUM Growth
+$49M
(+19%)
Cap. Flow
+$24.2M
Cap. Flow
% of AUM
7.75%
Top 10 Holdings %
Top 10 Hldgs %
48.72%
Holding
62
New
16
Increased
14
Reduced
12
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$10.5M |
| 2 |
PAY
Verifone Systems Inc
PAY
|
+$10.2M |
| 3 |
Hain Celestial
HAIN
|
+$8.59M |
| 4 |
PDLI
PDL BioPharma, Inc.
PDLI
|
+$8.35M |
| 5 |
ACOR
Acorda Therapeutics
ACOR
|
+$7.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGI
Somnigroup International
SGI
|
+$7.97M |
| 2 |
TLRD
Tailored Brands, Inc.
TLRD
|
+$6.9M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$6.59M |
| 4 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$6.26M |
| 5 |
Sanofi
SNY
|
+$5.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.45% |
| 2 | Consumer Discretionary | 17.85% |
| 3 | Consumer Staples | 13.73% |
| 4 | Technology | 2.85% |
| 5 | Communication Services | 1.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
SCYNEXIS
SCYX
$36M
| – | – |
-8,725
| Closed | -$1.51M |
|
|
52
Sanofi
SNY
$109B
| – | – |
-138,000
| Closed | -$5.78M |
|
|
XYLO
53
DELISTED
Xylo Technologies
XYLO
| – | – |
-387
| Closed | -$625K |
|
|
SGI
54
Somnigroup International
SGI
$15.2B
| – | – |
-576,000
| Closed | -$7.97M |
|
|
AVTA
55
DELISTED
Avantax, Inc. Common Stock
AVTA
| – | – |
-500,000
| Closed | -$5.18M |
|
|
LEAF
56
DELISTED
Leaf Group Ltd.
LEAF
| – | – |
-720,000
| Closed | -$3.72M |
|
|
HABT
57
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| – | – |
-236,000
| Closed | -$3.87M |
|
|
DFRG
58
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| – | – |
-272,000
| Closed | -$3.9M |
|
|
HZNP
59
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-400,000
| Closed | -$6.59M |
|
|
NILE
60
DELISTED
Blue Nile, Inc.
NILE
| – | – |
-148,000
| Closed | -$4.05M |
|
|
BDSI
61
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| – | – |
-2,652,000
| Closed | -$6.26M |
|
Similar funds
CRC
RMDI
F
DWM
DCP
EW
AIM
O
Armistice Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Armistice Capital held 62 positions worth $312M, up 19% from $263M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Armistice Capital deployed $24.2M of net new capital in Q3 2016, opening 16 new positions and adding to 14 existing holdings. Its largest new stake was Pacira BioSciences: 268,000 shares worth $9.17M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Tailored Brands, Inc., an estimated $6.9M trimmed.
- Armistice Capital's largest Q3 2016 buy was Pacira BioSciences: 268,000 shares worth $9.17M.
- Armistice Capital added most to Hain Celestial in Q3 2016, an estimated $8.59M increase.
- Armistice Capital's biggest Q3 2016 reduction was Tailored Brands, Inc., cutting an estimated $6.9M.
- Armistice Capital fully exited Somnigroup International in Q3 2016, selling an estimated $7.97M.
- Armistice Capital's ten largest holdings make up 49% of its $312M portfolio in Q3 2016.
- Armistice Capital opened 16 new positions and closed 19 in Q3 2016.
- Armistice Capital's portfolio value rose 19% quarter-over-quarter to $312M.
Based on Armistice Capital's 13F filing for Q3 2016, filed 14 Nov 2016.